Cargando…
Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study
INTRODUCTION: Surgery for N2 stage IIIA NSCLC is not recommended in major guidelines. Nevertheless, it has been noted that single-station N2 may have a better prognosis than multistation N2 and that surgery can be performed as the main therapeutic option. METHODS: We conducted a prospective phase II...
Autores principales: | Abe, Jiro, Matsumura, Yuji, Shiono, Satoshi, Aoki, Masaya, Sato, Masami, Oura, Hiroyuki, Kato, Hirohisa, Minowa, Muneo, Oizumi, Hiroyuki, Sagawa, Motoyasu, Sakurada, Akira, Okada, Yoshinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474189/ https://www.ncbi.nlm.nih.gov/pubmed/34589926 http://dx.doi.org/10.1016/j.jtocrr.2020.100019 |
Ejemplares similares
-
A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer—Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study
por: Hasegawa, Takeo, et al.
Publicado: (2020) -
Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma
por: Matsumura, Yuki, et al.
Publicado: (2023) -
From the IASLC Tobacco Control Committee
Publicado: (2020) -
From the IASLC Tobacco Control Committee
Publicado: (2020) -
From the IASLC Tobacco Control Committee
Publicado: (2020)